Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host Cells and Extracellular Matrix Proteins is a collective term describing the cellular and structural environment of biological tissues rather than a specific, individual molecular target. Host cells are the living cells of an organism that can be infected by pathogens or targeted by therapies, while the extracellular matrix (ECM) is a non-cellular three-dimensional network composed of macromolecules such as collagen, enzymes, and glycoproteins that provide structural support and regulate cell behavior (Source: NIH National Cancer Institute). In a therapeutic context, specific elements within this category are targeted; for example, integrins on host cells are targeted to prevent inflammation, and ECM-degrading enzymes are used to treat fibroproliferative disorders (Source: Nature Reviews Drug Discovery). Because the term encompasses a vast array of distinct proteins and cell types with diverse functions, it is generally classified as a broad biological compartment or site of action rather than a single druggable receptor or enzyme (Source: StatPearls). Drugs that interact with these components typically function by inhibiting cell-matrix adhesion, disrupting structural integrity to enhance drug penetration, or blocking receptors used by viruses for entry (Source: PubMed). This category is critical in understanding disease progression in cancer metastasis and chronic fibrosis, where the remodeling of the matrix plays a central role in pathology (Source: Journal of Cell Biology).
Modulation of cell-matrix interactions, enzymatic degradation of structural matrix components, or competitive inhibition of host cell surface receptors used for adhesion and signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host Cells and Extracellular Matrix Proteins.